| Dr Stephen John Forest, MD | |
|
3400 Bainbridge Ave, Map 5, Bronx, NY 10467-2404 | |
| (718) 920-5790 | |
| (718) 881-5074 |
| Full Name | Dr Stephen John Forest |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 16 Years |
| Location | 3400 Bainbridge Ave, Bronx, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942597083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 275888 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Today's headlines highlight coverage of the political implications of health reform as well as action taken by the nation's two largest insurers to meet a requirement of the new health law early.
METTLER TOLEDO has announced a new online seminar, titled Flow Chemistry Development and Scale-up. Each presentation includes examples of how simple PAT tools have become integrated into continuous flow chemistry to expedite process development. Each presenter will share a series of technical case studies.
When heart failure patients receive a heart pumping device known as a left ventricular assist device (LVAD), their caregivers seem to suffer, too - at least initially, according to research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug sorafenib can reduce the size of large tumors and could be safely undertaken administered without adding significantly to the risks of surgery.
› Verified 2 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Today's headlines highlight coverage of the political implications of health reform as well as action taken by the nation's two largest insurers to meet a requirement of the new health law early.
METTLER TOLEDO has announced a new online seminar, titled Flow Chemistry Development and Scale-up. Each presentation includes examples of how simple PAT tools have become integrated into continuous flow chemistry to expedite process development. Each presenter will share a series of technical case studies.
When heart failure patients receive a heart pumping device known as a left ventricular assist device (LVAD), their caregivers seem to suffer, too - at least initially, according to research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug sorafenib can reduce the size of large tumors and could be safely undertaken administered without adding significantly to the risks of surgery.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen John Forest, MD 3400 Bainbridge Ave, Map 5, Bronx, NY 10467-2404 Ph: (718) 920-5790 | Dr Stephen John Forest, MD 3400 Bainbridge Ave, Map 5, Bronx, NY 10467-2404 Ph: (718) 920-5790 |
News Archive
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Today's headlines highlight coverage of the political implications of health reform as well as action taken by the nation's two largest insurers to meet a requirement of the new health law early.
METTLER TOLEDO has announced a new online seminar, titled Flow Chemistry Development and Scale-up. Each presentation includes examples of how simple PAT tools have become integrated into continuous flow chemistry to expedite process development. Each presenter will share a series of technical case studies.
When heart failure patients receive a heart pumping device known as a left ventricular assist device (LVAD), their caregivers seem to suffer, too - at least initially, according to research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer Center found that therapy before surgery with the drug sorafenib can reduce the size of large tumors and could be safely undertaken administered without adding significantly to the risks of surgery.
› Verified 2 days ago
Daniel Goldstein, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: May Accept Medicare Assignments Practice Location: Mmc - Dept. Of Ct Surgery, 3400 Bainbridge Avenue, Bronx, NY 10467 Phone: 718-920-7000 | |
Steven M Keller, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 1575 Blondell Ave, Suite 125, Bronx, NY 10461 Phone: 718-405-8378 Fax: 718-405-8253 | |
Elizabeth Katz, Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-4321 | |
Lari A Attai, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: Mmc - Dept. Of Ct Surgery, 3316 Rochambeau Avenue, Bronx, NY 10467 Phone: 718-920-7315 | |
Ms. Nicole Virginia Pagones, PA-C Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-4321 | |
Rachel Spallone, Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 110 E 210th St, Bronx, NY 10467 Phone: 718-920-8874 | |
Dr. Enrique Augusto Bonfils-roberts, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 234 E 149th St, 620, Bronx, NY 10451 Phone: 718-579-5900 Fax: 718-579-4620 |